# Final Review

**Purpose:** Log the paper's final state after all revisions
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Timestamp:** 2026-01-28T18:53:54.042792
**Response ID:** resp_02c4868a31bbb49a00697a4c8d71e08197862b2efb8603762f
**Tokens:** 16418 in / 5818 out
**Response SHA256:** 9cccfb2ed1d64ade

---

## Referee Report (Top General-Interest Economics Journal)

### Summary
The paper asks whether Extreme Risk Protection Order (ERPO) laws reduce suicide. Using a 1999–2017 state-year panel and staggered DiD (Callaway–Sant’Anna), the paper finds a positive ATT on total suicide (≈ +0.53 deaths per 100,000; Table 3), while TWFE is negative and insignificant. The authors appropriately caution that inference is unreliable with only 3 treated clusters in the main specification and suggest the positive estimate likely reflects policy endogeneity (reverse causation).

This paper, in its current form, is **not publishable in a top economics journal**. The core problem is not merely “low power”: it is **fundamental identification and inference failure** given (i) essentially **three treated clusters** (and effectively two with meaningful post-periods), (ii) **highly endogenous policy timing**, and (iii) **insufficient post-treatment support** for key cohorts (CA has 2 post years; WA has 1). The paper could become valuable if reframed as a methodological cautionary note *and* paired with an empirically credible research design and valid few-treated inference.

Below I provide a demanding checklist-style review with concrete fixes.

---

# 1. FORMAT CHECK

### Length
- The PDF page numbering in the provided excerpt runs to **p. 28** including appendix/code; **main text ends around p. 20** (Conclusion on p. 19–20; References begin around p. 22).
- AER/QJE/JPE/ReStud/ECMA typically expect **≥25 pages of main text** (excluding references/appendix). **This falls short** unless substantial content is moved into the main body and expanded.

### References coverage
- Methodology citations are partially adequate (Callaway & Sant’Anna; Goodman-Bacon; de Chaisemartin & D’Haultfoeuille; Sun & Abraham; Borusyak et al.; Roth).
- Domain literature is **thin** for a policy evaluation paper on suicide and firearms. You cite several key items (Barber & Miller; Smart et al. RAND; Swanson et al.; Kivisto/Phalen), but the paper does not adequately engage the broader causal firearms–suicide policy literature or the emerging ERPO empirical literature (details in Section 4 below).

### Prose vs bullets
- Most sections are in paragraph form (Intro, Data, Empirical Strategy, Results).
- However, **Section 6.1 (Discussion)** uses bullet-like enumerations (“Several factors support this interpretation: TWFE vs C-S discordance… Outcome mismatch… Limited treated units…”) that read like notes rather than journal prose. Top journals strongly prefer **fully developed paragraphs** for central interpretation.

### Section depth
- Intro (Section 1): yes, multiple substantive paragraphs.
- Institutional background (Section 2): yes.
- Data (Section 3): yes.
- Empirical strategy (Section 4): yes.
- Results (Section 5): borderline—main results are short and rely heavily on caveats rather than deep analysis; event study interpretation is underdeveloped.
- Discussion (Section 6): yes in length, but much is cautionary; it needs deeper engagement with mechanisms and alternative designs.

### Figures
- Figures shown (event study, trends, map, pre-trends) have axes and visible data.
- But **publication quality is not yet there**: the event-study plot (Figure 1) and pre-trends plot (Figure 4) look like default ggplot outputs with small fonts and limited clarity about support (which cohorts contribute at each event time). For a top outlet, you must show:
  - event-time support (“# states contributing”) by relative year,
  - clear labeling of the comparison group and estimator,
  - consistent y-axis scaling and readable CI bands.

### Tables
- Tables contain real numbers (no placeholders).
- Table 4 notes that DR/IPW/OR coincide because xformla=~1; this is an important red flag (see below).

---

# 2. STATISTICAL METHODOLOGY (CRITICAL)

### (a) Standard errors
- **Pass mechanically**: Table 3 reports SEs in parentheses; Table 3 includes 95% CIs; N is reported.
- **Fail substantively**: with **3 treated clusters**, conventional clustered SEs and the “analytical SEs” in did are not credible for hypothesis testing, as you acknowledge (Section 4.3; Figure notes). In a top journal, this is not an acceptable stopping point: you must implement **few-treated-cluster inference**.

### (b) Significance testing
- You report CIs but repeatedly disclaim inference. This is effectively “no valid inference.”
- A general-interest journal will not accept “SEs are unreliable, but here they are.”

### (c) Confidence intervals
- Reported (Table 3). But again: not valid under the design as implemented.

### (d) Sample sizes
- Reported for main regressions (Table 3). Good.

### (e) DiD with staggered adoption
- You correctly avoid relying only on TWFE and use Callaway–Sant’Anna. **Pass on estimator choice.**
- However, two issues undermine credibility:
  1. **Treatment support problem**: WA has **1** post year; CA has **2** post years. Dynamic effects are largely extrapolation/noise.
  2. **No covariates whatsoever**: Table 4 notes xformla=~1, which makes DR/IPW/OR identical. For policy adoption that is clearly endogenous, an unconditional DID is extremely fragile.

### (f) RDD
- Not applicable.

## Bottom line on methodology
Even though the paper uses a modern staggered-DiD estimator, the paper **does not meet the “proper inference” bar** required by the prompt and by top journals. With 3 treated clusters, you need at least one of:

1. **Randomization inference / permutation inference** tailored to staggered adoption (or cohort-level adoption), reporting exact or placebo-based p-values and Fisher-style intervals.
2. **Conley–Taber (2011)**-style inference (or extensions) explicitly designed for few policy changes.
3. **Wild cluster bootstrap** methods appropriate for few clusters (with careful implementation given staggered DiD and cohort-time ATTs).
4. A redesigned unit of analysis (e.g., county-level) that yields many treated clusters and plausibly exogenous variation.

Without this, the paper is **unpublishable**.

---

# 3. IDENTIFICATION STRATEGY

### Credibility
- Identification is **not credible** as a causal estimate of ERPO effects on total suicide.
- You essentially concede this in the Abstract and Discussion (reverse causation; thin identifying variation; dubious parallel trends). This is honest, but it also means the paper currently does not deliver a credible answer to its title question.

### Key assumptions
- Parallel trends is discussed (Section 4.1; event study Section 5.2).
- But the event-study evidence is not used rigorously:
  - You show volatility and mention problematic pre-trends, yet you do not quantify pre-trend violations in a way that translates into bounds on the ATT.

### Placebos and robustness
- Table 4 robustness is mostly superficial because the design has little information:
  - DR/IPW/OR equality indicates **no adjustment** and thus minimal robustness.
  - “Not-yet-treated controls” is good to show, but with adoption after 2017, this is mostly a labeling choice.
- Missing robust checks expected at this tier:
  - **Pre-trend sensitivity/bounds** (Rambachan–Roth style).
  - **Leave-one-treated-state-out** (you do variants excluding WA; but you need a systematic leave-one-out across cohorts and show how estimates hinge on Indiana vs California).
  - **Negative-control outcomes** (e.g., deaths unlikely to be affected by ERPO) to diagnose spurious correlations.
  - **Policy bundle controls** (other gun policies; opioid policies; mental health spending; unemployment; etc.).
  - **Alternative outcomes aligned with mechanism**: firearm suicides, nonfirearm suicides, firearm ownership proxies.

### Conclusions vs evidence
- The paper mostly avoids overclaiming and emphasizes caution. That is good.
- But the headline framing (“Do ERPO laws reduce suicide?”) is inconsistent with the admitted inability of the design to identify causality. In a top journal, either:
  1) you must produce a credible causal design; or
  2) you must reframe the contribution as “Why early-adopter state DiD cannot answer this question” and provide methodological/general lessons with demonstrably valid inference.

### Limitations
- Limitations are discussed extensively (Section 6). This is a strength, but also an implicit admission the current design cannot support the main claim.

---

# 4. LITERATURE (missing references + BibTeX)

## (A) Methods: few-treated inference and DiD sensitivity
You cite Conley–Taber (2011) and Cameron–Gelbach–Miller (2008), but you do **not** implement their logic nor cite key modern sensitivity/bounding papers needed given the pre-trend concerns.

**Add and use:**
- Rambachan & Roth (pre-trends sensitivity/bounds).  
```bibtex
@article{RambachanRoth2023,
  author  = {Rambachan, Ashesh and Roth, Jonathan},
  title   = {A More Credible Approach to Parallel Trends},
  journal = {Review of Economic Studies},
  year    = {2023},
  volume  = {90},
  number  = {5},
  pages   = {2555--2591}
}
```

- MacKinnon & Webb on wild cluster bootstrap with few clusters (at minimum; ideally implement).  
```bibtex
@article{MacKinnonWebb2017,
  author  = {MacKinnon, James G. and Webb, Matthew D.},
  title   = {Wild Bootstrap Inference for Wildly Different Cluster Sizes},
  journal = {Journal of Applied Econometrics},
  year    = {2017},
  volume  = {32},
  number  = {2},
  pages   = {233--254}
}
```

- (Optional but useful for implementation discussion) Roodman et al. on wild bootstrap practice.  
```bibtex
@article{RoodmanEtAl2019,
  author  = {Roodman, David and Nielsen, Morten {\O}rregaard and MacKinnon, James G. and Webb, Matthew D.},
  title   = {Fast and Wild: Bootstrap Inference in Stata Using boottest},
  journal = {Stata Journal},
  year    = {2019},
  volume  = {19},
  number  = {1},
  pages   = {4--60}
}
```

## (B) Firearm policy and suicide literature (core empirical context)
A top outlet will expect engagement with the canonical causal literature on firearm access restrictions and suicide (waiting periods, permit-to-purchase, background checks).

**Add:**
- Waiting periods and gun deaths (includes suicide).  
```bibtex
@article{LucaMalhotraPoliquin2017,
  author  = {Luca, Michael and Malhotra, Deepak and Poliquin, Christopher},
  title   = {Handgun Waiting Periods Reduce Gun Deaths},
  journal = {Proceedings of the National Academy of Sciences},
  year    = {2017},
  volume  = {114},
  number  = {46},
  pages   = {12162--12165}
}
```

- Permits / purchase regulations and firearm suicides (representative example; you should choose the most relevant based on your actual framing/data). A commonly cited entry point is the permit-to-purchase literature; if you focus on suicide, cite studies that separate firearm vs nonfirearm suicide where possible.

*(Because the permit-to-purchase literature is large and paper-specific, you should add 2–4 of the most relevant peer-reviewed causal papers and explicitly connect them to your mechanism/outcome mismatch point.)*

## (C) ERPO-specific empirical literature beyond CT/IN case studies
You cite Swanson et al. (2017) and Kivisto et al. (2018). That is not enough for 2026. There is now a broader public health and criminology literature on ERPO uptake, county heterogeneity, and downstream outcomes (often firearm suicide or firearm removals). The paper must engage it and clarify what is new relative to it.

*(I cannot safely invent citations; you should add the key ERPO causal/quantitative papers published since 2018 and explain differences in outcomes, unit of analysis, and identification.)*

---

# 5. WRITING QUALITY (CRITICAL)

### Prose vs bullets
- Mostly prose, but Section 6.1 is written as a list of talking points rather than journal-quality argumentation. Convert to paragraphs with topic sentences, evidence, and transitions.

### Narrative flow
- The introduction is competent and motivated (lethality, impulsivity, means restriction). Good.
- The narrative breaks when the main result is “positive but probably reverse causation”; after that, the paper reads like a technical memo documenting why the design fails, rather than a coherent causal story with a credible research design.

### Sentence quality and accessibility
- Generally clear and readable. Technical terms are mostly explained.
- But there is too much “hedging-by-disclaimer.” Top outlets accept caveats, but they require a design that still identifies something credible.

### Tables/figures
- Tables have decent notes.
- Figures need “support” indicators and clearer annotation. For example, Figure 1 should show which cohorts contribute at each event time (especially given WA and CA’s tiny post windows).

---

# 6. CONSTRUCTIVE SUGGESTIONS (to make it publishable)

## A. Redesign the empirical strategy (most important)
Right now the paper has **too few treated units** and **too little post-treatment** to answer the question credibly. You have several options:

1. **Extend the panel through at least 2023/2024** and include the 2018–2019 adoption wave.  
   - This directly fixes “only 3 treated clusters” and the CA/WA post-period problem.
   - Then Callaway–Sant’Anna (or Borusyak–Jaravel–Spiess) becomes informative.

2. **Use firearm suicide outcomes** (CDC WONDER X72–X74) and separate nonfirearm suicides.  
   - If suppression is a concern, use multi-year pooling (e.g., 3-year rolling rates), or move to **county-level** where counts are larger in aggregate, or use restricted-access mortality microdata.
   - Mechanism alignment is essential; total suicide is a weak proxy.

3. **Exploit intensity / utilization** rather than “law-on-the-books.”  
   - Collect ERPO petitions/orders by county-year (many states publish reports; courts often have administrative data).
   - Then estimate dose-response models and event studies of adoption *and* ramp-up.

4. **Adopt an alternative design for early adopters**:
   - **Synthetic control / augmented synthetic control** for Indiana and Connecticut, with placebo-in-space tests and transparent donor pools.
   - A credible paper could be “Two early adopters: synthetic control evidence on firearm suicide.”

## B. Fix inference properly
Even with a larger sample, you must pre-specify inference that is valid under your design:

- If still few treated: implement **randomization inference** (assignment of adoption years among donor states) and report Fisher p-values and randomization-based intervals.
- If many treated: clustered SEs may be acceptable, but still consider **wild cluster bootstrap** given serial correlation and policy clustering.

## C. Address pre-trends formally
Implement Rambachan–Roth sensitivity:
- Translate observed pre-trend deviations into **bounds** on the post-treatment effect under explicit restrictions on trend violations.
- This is far more informative than “pre-trends look volatile.”

## D. Add a minimal set of covariates / policy controls
At this tier, xformla=~1 is not credible given policy endogeneity. Add:
- unemployment, income, opioid mortality, mental health spending proxies,
- other firearm policies (waiting periods, permit-to-purchase, background checks, CAP laws),
- possibly state-specific linear trends (with clear discussion of pros/cons).

## E. Reframe the contribution honestly
If you keep the early-adopter-only approach, the publishable contribution is not “ERPOs increase suicide.” It is:
- “Early adopter ERPO evaluation via state DiD is not identified; here is a rigorous demonstration and what designs/data are needed.”
That can be valuable, but only if paired with **formal inference/bounding** and a clear methodological message.

---

# 7. OVERALL ASSESSMENT

### Strengths
- Important question with high policy salience.
- Correct awareness of staggered DiD pitfalls; appropriate use of Callaway–Sant’Anna.
- Transparent discussion of limitations and endogeneity concerns.
- Replication-oriented mindset (API-based data; code pipeline described).

### Critical weaknesses (publication-stopping)
1. **Inference is not valid** with 3 treated clusters; you do not implement any few-treated inference.
2. **Identification is not credible**: adoption is endogenous to trends; pre-trends look problematic; post-period support is extremely thin for CA/WA.
3. **Outcome mismatch**: total suicide is not tightly linked to ERPO mechanism; this makes null/attenuated results hard to interpret.
4. **Insufficient main-text length and journal-style exposition** (reads like a technical report; too many disclaimers; insufficient deep analysis of mechanisms and alternative explanations).

### What would change my view
- Extending the data to include the 2018–2019 wave + firearm suicide outcomes + valid inference would turn this into a potentially publishable AEJ:EP-style paper.
- Alternatively, a tightly executed synthetic control study of Indiana/Connecticut with rigorous placebo inference could be publishable if framed appropriately.

---

DECISION: REJECT AND RESUBMIT